India · Delayed Price · Currency is INR Banka BioLoo Statistics
Total Valuation
Banka BioLoo has a market cap or net worth of INR 655.61 million. The enterprise value is 960.52 million.
| Market Cap | 655.61M |
| Enterprise Value | 960.52M |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Banka BioLoo has 10.87 million shares outstanding. The number of shares has increased by 1.07% in one year.
| Current Share Class | 10.87M |
| Shares Outstanding | 10.87M |
| Shares Change (YoY) | +1.07% |
| Shares Change (QoQ) | -2.01% |
| Owned by Insiders (%) | 52.43% |
| Owned by Institutions (%) | n/a |
| Float | 5.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.21 |
| PB Ratio | 2.14 |
| P/TBV Ratio | 2.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -33.66 |
| EV / Sales | 1.77 |
| EV / EBITDA | 56.98 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.06 |
| Debt / EBITDA | 19.93 |
| Debt / FCF | n/a |
| Interest Coverage | -0.34 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -1.88% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.18% |
| Revenue Per Employee | 489,208 |
| Profits Per Employee | -25,728 |
| Employee Count | 1,109 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -8.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.17% in the last 52 weeks. The beta is 0.17, so Banka BioLoo's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -16.17% |
| 50-Day Moving Average | 63.78 |
| 200-Day Moving Average | 75.53 |
| Relative Strength Index (RSI) | 39.51 |
| Average Volume (20 Days) | 4,924 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Banka BioLoo had revenue of INR 542.53 million and -28.53 million in losses. Loss per share was -2.63.
| Revenue | 542.53M |
| Gross Profit | 111.78M |
| Operating Income | -11.46M |
| Pretax Income | -36.77M |
| Net Income | -28.53M |
| EBITDA | 10.72M |
| EBIT | -11.46M |
| Loss Per Share | -2.63 |
Balance Sheet
The company has 19.66 million in cash and 323.93 million in debt, with a net cash position of -304.26 million or -27.98 per share.
| Cash & Cash Equivalents | 19.66M |
| Total Debt | 323.93M |
| Net Cash | -304.26M |
| Net Cash Per Share | -27.98 |
| Equity (Book Value) | 306.90M |
| Book Value Per Share | 28.23 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 20.60%, with operating and profit margins of -2.11% and -5.26%.
| Gross Margin | 20.60% |
| Operating Margin | -2.11% |
| Pretax Margin | -6.78% |
| Profit Margin | -5.26% |
| EBITDA Margin | 1.98% |
| EBIT Margin | -2.11% |
| FCF Margin | n/a |
Dividends & Yields
Banka BioLoo does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.07% |
| Shareholder Yield | -1.07% |
| Earnings Yield | -4.35% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 8, 2020. It was a forward split with a ratio of 2.5.
| Last Split Date | Sep 8, 2020 |
| Split Type | Forward |
| Split Ratio | 2.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |